ARAlejandra Romero-Utrilla

Alejandra Romero-Utrilla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alejandra Romero-Utrilla has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antiviral Effect of Microalgae Phaeodactylum tricornutum Protein Hydrolysates against Dengue Virus Serotype 2

    by Bianca Vianey Rivera-Serrano, Sandy Lucero Cabanillas-Salcido, Carlos Daniel Cordero-Rivera, Ricardo Jiménez-Camacho, Claudia Desiree Norzagaray-Valenzuela, Loranda Calderón-Zamora, Luis Adrián De Jesús-González, José Manuel Reyes-Ruiz, Carlos Noe Farfan-Morales, Alejandra Romero-Utrilla, et al.

    Dengue, caused by the dengue virus (DENV), is a global health threat transmitted by Aedes mosquitoes, resulting in 400 million cases annually. The disease ranges from mild to severe, with potential progression to hemorrhagic dengue. Current research is focused on natural antivirals due to challenges in vector control. This study evaluates the antiviral potential of peptides derived from the microalgae Phaeodactylum tricornutum, known for its bioactive compounds. Microalgae were cultivated under controlled conditions, followed by protein extraction and hydrolysis to produce four peptide fractions. These fractions were assessed for cytotoxicity via the MTT assay and antiviral activity against DENV serotype 2 using flow cytometry and plaque formation assays. The 10–30 kDa peptide fraction, at 150 and 300 μg/mL concentrations, demonstrated no cytotoxicity and significantly reduced the percentage of infected cells and viral titers. These findings suggest that peptides derived from Phaeodactylum tricornutum exhibit promising antiviral activity against dengue virus serotype 2, potentially contributing to developing new therapeutic approaches for dengue.


  • Open Access

    Myxoid Endometriosis: An Entity That Can Cause Confusion with Malignant Entities

    by Saulo Mendoza-Ramirez, Claudia Mariana Hernández-Robles, Italú Velasco-Rueda, Alejandra Romero-Utrilla, Myrna Doris Arrecillas-Zamora, Eduardo Agustín-Godínez, Lourdes Lucía Morales-Jáuregui, Lázaro Ariel Ramírez-Balderrama, Marco Antonio Olvera-Olvera, Mario Murguia-Perez

    Myxoid endometriosis, a rare entity, is part of the histological changes that can occur in endometriosis. Pathologists must know the histological guidelines for the morphological recognition of this entity, as well as the histochemical and immunohistochemical techniques that support diagnosis, and define the morphological characteristics of myxoid endometriosis. In the present work, we propose diagnostic guidelines and primary differential diagnoses using special histochemical techniques and immunohistochemical reactions to recognize this entity.

  • Open Access

    Clinical Predictors of Monkeypox Diagnosis: A Case-Control Study in a Nonendemic Region during the 2022 Outbreak

    by Alberto Kousuke De la Herrán-Arita, Cuitláhuac González-Galindo, Gerardo Kenny Inzunza-Leyva, Marco Antonio Valdez-Flores, Claudia Desiree Norzagaray-Valenzuela, Alejandro Camacho-Zamora, José Candelario Batiz-Beltrán, Francisco Javier Urrea-Ramírez, Alejandra Romero-Utrilla, Carla Angulo-Rojo, et al.

    Monkeypox (Mpox) is an emerging zoonotic disease with the potential for severe complications. Early identification and diagnosis are essential to prompt treatment, control its spread, and reduce the risk of human-to-human transmission. This study aimed to develop a clinical diagnostic tool and describe the clinical and sociodemographic features of 19 PCR-confirmed Mpox cases during an outbreak in a nonendemic region of northwestern Mexico. The median age of patients was 35 years, and most were male. Mpox-positive patients commonly reported symptoms such as fever, lumbago, and asthenia, in addition to experiencing painful ulcers and a high frequency of HIV infection among people living with HIV (PLWH). Two diagnostic models using logistic regression were devised, with the best model exhibiting a prediction accuracy of 0.92 (95% CI: 0.8–1), a sensitivity of 0.86, and a specificity of 0.93. The high predictive values and accuracy of the top-performing model highlight its potential to significantly improve early Mpox diagnosis and treatment in clinical settings, aiding in the control of future outbreaks.


  • Open Access

    Myxoid Endometriosis: An Entity That Can Cause Confusion with Malignant Entities

    by Saulo Mendoza-Ramirez, Claudia Mariana Hernández-Robles, Italú Velasco-Rueda, Alejandra Romero-Utrilla, Myrna Doris Arrecillas-Zamora, Eduardo Agustín-Godínez, Lourdes Lucía Morales-Jáuregui, Lázaro Ariel Ramírez-Balderrama, Marco Antonio Olvera-Olvera, Mario Murguia-Perez

    Myxoid endometriosis is a rare entity that is part of the histological changes that can occur in endometriosis. It is extremely important that the pathologist has knowledge of the histological guidelines for the morphological recognition of this entity, as well as the histochemical and immunohistochemical techniques that will support the diagnosis. Define the morphological characteristics of myxoid endometriosis. In the present work we propose diagnostic approach guidelines, as well as the main differential diagnoses with the use of special histochemical techniques and immunohistochemical reactions to recognize this entity.

  • Open Access

    The Usefulness of Peripheral Blood Cell Counts to Distinguish COVID-19 from Dengue during Acute Infection

    by Juan Fidel Osuna-Ramos, José Manuel Reyes-Ruiz, Luis Antonio Ochoa-Ramírez, Luis Adrián De Jesús-González, Rosalío Ramos-Payán, Carlos Noe Farfan-Morales, Alejandra Romero-Utrilla, Efrén Rafael Ríos-Burgueño, José Rodríguez-Millán, Rosa María del Ángel, et al.

    COVID-19 and dengue disease are challenging to tell apart because they have similarities in clinical and laboratory features during the acute phase of infection, leading to misdiagnosis and delayed treatment. The present study evaluated peripheral blood cell count accuracy to distinguish COVID-19 non-critical patients from non-severe dengue cases between the second and eleventh day after symptom onset. A total of 288 patients infected with SARS-CoV-2 (n = 105) or dengue virus (n = 183) were included in this study. Neutrophil, platelet, and lymphocyte counts were used to calculate the neutrophil–lymphocyte ratio (NLR), the platelet–lymphocyte ratio (PLR), and the neutrophil–lymphocyte*platelet ratio (NLPR). The logistic regression and ROC curves analysis revealed that neutrophil and platelet counts, NLR, LPR, and NLPR were higher in COVID-19 than dengue. The multivariate predictive model showed that the neutrophils, platelets, and NLPR were independently associated with COVID-19 with a good fit predictive value (p = 0.1041). The neutrophil (AUC = 0.95, 95% CI = 0.84–0.91), platelet (AUC = 0.89, 95% CI = 0.85–0.93) counts, and NLR (AUC = 0.88, 95% CI = 0.84–0.91) were able to discriminate COVID-19 from dengue with high sensitivity and specificity values (above 80%). Finally, based on predicted probabilities on combining neutrophils and platelets with NLR or NLPR, the adjusted AUC was 0.97 (95% CI = 0.94–0.98) to differentiate COVID-19 from dengue during the acute phase of infection with outstanding accuracy. These findings might suggest that the neutrophil, platelet counts, and NLR or NLPR provide a quick and cost-effective way to distinguish between dengue and COVID-19 in the context of co-epidemics in low-income tropical regions.


  • Open Access

    Serum lipid profile changes and their clinical diagnostic significance in COVID-19 Mexican Patients

    by Juan Fidel Osuna-Ramos, Horacio Rendón-Aguilar, Luis Adrián De Jesús-González, José Manuel Reyes-Ruiz, Arely Montserrat Espinoza-Ortega, Luis Antonio Ochoa-Ramírez, Alejandra Romero-Utrilla, Efrén Ríos-Burgueño, Alejandro Soto-Almaral, Juan José Ríos-Tostado, et al.

    Background: COVID-19 has been recognized as an emerging and rapidly evolving health condition. For this reason, efforts to determine changes in laboratory parameters of COVID-19 patients as biomarkers are urgent. Lipids are essential components of the human body, and their modulation has been observed implicated in some viral infections. Methods: To evaluate the clinical diagnosis utility of the lipid profile changes in Mexican COVID-19 patients, the lipid profile of one hundred two COVID-19 positive patients from three hospitals in Culiacan, Sinaloa in northwest Mexico, was analyzed. ROC curves and binary logistic regression analysis were used as a predictive model to determine their clinical diagnostic utility. Results: Significant changes in the serum lipid profile of patients with COVID-19, such as low levels of cholesterol, LDL, and HDL, while high triglycerides and VLDL were observed. The same abnormalities in the lipid profile among non-critical and critical COVID-19 patients were detected. The predictive model analysis suggests that cholesterol and LDL have AUC values of 0.710 and 0.769, respectively, for COVID-19 (p= 0.0002 and p= <0.0001), and LDL low levels might be a risk factor for critical COVID-19 (OR= 2.07, 95% IC: 1.18 to 3.63; p= 0.01). Conclusion: Our findings suggest that low cholesterol and LDL levels could be considered an acceptable predictor for COVID-19, and low levels of LDL might be a risk factor for critical COVID-19 patients.